Home -> Law Blog Directory -> Federal Judiciary Blogs -> Eastern District of Texas Federal Court Practice
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Federal Judiciary
: Eastern District of Texas Federal Court PracticeDataTreasury trial concludes
By Michael C. Smith
The long-awaited DataTreasury trial before Judge David Folsom in Marshall concluded yesterday. The jury found infringement and willful infringement as to some claims, as well as that the invalidity defenses had not been proven by clear and convincing evidence. Plaintiff asked the jury for $201 million, but the jury awarded about a ninth of that - $27 million.
I have not yet posted on them, but there was a blizzard of rulings by Judges Folsom and Everingham before and during the trial re: the admissibility of settlement licenses based in part on the recent Federal Circuit caselaw on that point, as well as a denial by the FC of a petition for mandamus on the court's order on that point. There was a limiting instruction that they could not be considered for infringement, but that they could be considered for willfulness, obviousness, or royalty damages. There were at least a couple of dozen, so it will be intereting to see which were in and which and which with what instruction.
Full post as published by Eastern District of Texas Federal Court Practice on March 27, 2010 (boomark / email).
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Arbitration Agreement Does Not Encumber Patent
Edward Jones takes license from DataTreasury
Alberto Gonzales and the Datatreasury Case Files
Licensors successor is not bound by arbitration clause in license agreement
What Will Become of the "Check 21" Patent Reform Provision








